Antagonist

Results: 956



#Item
31Identification and Characterization of a Potent Anti-Human TIM-3 Antagonist Copies of this poster obtained through Quick Response Code are for personal use only and may not be reproduced without permission from the autho

Identification and Characterization of a Potent Anti-Human TIM-3 Antagonist Copies of this poster obtained through Quick Response Code are for personal use only and may not be reproduced without permission from the autho

Add to Reading List

Source URL: www.tesarobio.com

Language: English - Date: 2014-12-02 13:02:25
    32April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014

    April 16, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014

    Add to Reading List

    Source URL: www.ajinomoto-seiyaku.co.jp

    Language: English - Date: 2014-04-14 23:44:58
      33May 13, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014

      May 13, 2014 Ajinomoto Pharmaceuticals Co., Ltd. Phase 2a Clinical Study Data of AJM300, an Oral α4 Integrin Antagonist, in Ulcerative Colitis Presented in Digestive Disease Week 2014

      Add to Reading List

      Source URL: www.ajinomoto-seiyaku.co.jp

      Language: English - Date: 2014-05-13 01:55:31
        34Challenges and Considerations for Conducting and Interpreting these Screening Assays Leah Zorrilla, PhD Investigative Toxicology Division Integrated Laboratory Systems (ILS), Inc.

        Challenges and Considerations for Conducting and Interpreting these Screening Assays Leah Zorrilla, PhD Investigative Toxicology Division Integrated Laboratory Systems (ILS), Inc.

        Add to Reading List

        Source URL: www.tera.org

        Language: English - Date: 2014-02-13 21:20:23
        35ModuleProposed Australian Consumer Medicine Information

        ModuleProposed Australian Consumer Medicine Information

        Add to Reading List

        Source URL: files.boehringer.com.au

        Language: English - Date: 2013-09-26 11:00:09
        36Resistenz der Wirtszelle gegen eine Infektion mit HIV

        Resistenz der Wirtszelle gegen eine Infektion mit HIV

        Add to Reading List

        Source URL: www.evolution-of-life.com

        Language: English
        371  Phase I Study of Safety and Pharmacokinetics of GDC-0917, an Antagonist of Inhibitor of Apoptosis Proteins in Patients with Refractory Solid Tumors or Lymphoma

        1 Phase I Study of Safety and Pharmacokinetics of GDC-0917, an Antagonist of Inhibitor of Apoptosis Proteins in Patients with Refractory Solid Tumors or Lymphoma

        Add to Reading List

        Source URL: www.curis.com

        Language: English - Date: 2014-05-12 19:51:02
          38zantac verses ranitidine, ranitidine prescription medicine ranitidine 75mg zantac ranitidine opinions ranitidine horses bleeding ranitidine childrens what is ranitidine. ranitidine zantac, ranitidine uses

          zantac verses ranitidine, ranitidine prescription medicine ranitidine 75mg zantac ranitidine opinions ranitidine horses bleeding ranitidine childrens what is ranitidine. ranitidine zantac, ranitidine uses

          Add to Reading List

          Source URL: blog.fabricinteractive.com

          Language: English - Date: 2015-07-19 21:24:19
          39losartan irbesartan blood pressure medications. irbesartan 75mg irbesartan hydrochlorothiazide side effects, hydrochlorothiazide and irbesartan amlodipine irbesartan avapro irbesartan, irbesartan ri on, irbesartan mecliz

          losartan irbesartan blood pressure medications. irbesartan 75mg irbesartan hydrochlorothiazide side effects, hydrochlorothiazide and irbesartan amlodipine irbesartan avapro irbesartan, irbesartan ri on, irbesartan mecliz

          Add to Reading List

          Source URL: novasom.com

          Language: English - Date: 2015-07-19 20:36:15
          40Title: Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. Abstract: (Your abstract must use 10pt Arial font and must not be longer than this box) The use of d

          Title: Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. Abstract: (Your abstract must use 10pt Arial font and must not be longer than this box) The use of d

          Add to Reading List

          Source URL: www.bps.ac.uk

          Language: English - Date: 2014-07-28 07:23:19